ConductScience.org, home

Paper39768384

Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial.

Rusic D and 9 others. Life (Basel), 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial. Papers, record 39768384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39768384

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial.
PubMed
Journal
Life (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.37, provisional
iCite
Revised in PubMed
2025-01-15
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT06189105Efficacy and Safety Assessment of Niacinamide Cosmetic Preparation: a Randomized Controlled TrialDerived from the trialYesClinicalTrials.gov
NCT07433907Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic DermatitisBackgroundClinicalTrials.gov

Download CSV of trials

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136693604Preparation of niacinamide imprinted starch-based biomaterials for treating of hyperpigmentation.Int J Biol Macromol2023https://conductscience.org/library/papers/36693604PubMed
237489567Skin Cancer Prevention across the G7, Australia and New Zealand: A Review of Legislation and Guidelines.Curr Oncol2023https://conductscience.org/library/papers/37489567PubMed
325645051Skin colour, skin redness and melanin biometric measurements: comparison study between Antera(®) 3D, Mexameter(®) and Colorimeter(®).Skin Res Technol2015https://conductscience.org/library/papers/25645051PubMed
438136732Innovative Approaches for Maintaining and Enhancing Skin Health and Managing Skin Diseases through Microbiome-Targeted Strategies.Antibiotics (Basel)2023https://conductscience.org/library/papers/38136732PubMed
535741330Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface.Biology (Basel)2022https://conductscience.org/library/papers/35741330PubMed
626916232The role of topical dermocosmetics in acne vulgaris.J Eur Acad Dermatol Venereol2016https://conductscience.org/library/papers/26916232PubMed
734148998Defining Skin Quality: Clinical Relevance, Terminology, and Assessment.Dermatol Surg2021https://conductscience.org/library/papers/34148998PubMed
827142709Cosmeceuticals: peptides, proteins, and growth factors.J Cosmet Dermatol2016https://conductscience.org/library/papers/27142709PubMed
937568569Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study.Cancers (Basel)2023https://conductscience.org/library/papers/37568569PubMed
1031835478Topical Delivery of Niacinamide: Influence of Binary and Ternary Solvent Systems.Pharmaceutics2019https://conductscience.org/library/papers/31835478PubMed
1130698874Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.Exp Dermatol2019https://conductscience.org/library/papers/30698874PubMed
1235337168Up-to-Date Overview of the Use of Natural Ingredients in Sunscreens.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35337168PubMed
1334834383Topical Delivery of Niacinamide to Skin Using Hybrid Nanogels Enhances Photoprotection Effect.Pharmaceutics2021https://conductscience.org/library/papers/34834383PubMed
1437113085In vivo transepidermal water loss: Validation of a new multi-sensor open chamber water evaporation system Tewameter TM Hex.Skin Res Technol2023https://conductscience.org/library/papers/37113085PubMed
1535209068A Mixture of Topical Forms of Polydeoxyribonucleotide, Vitamin C, and Niacinamide Attenuated Skin Pigmentation and Increased Skin Elasticity by Modulating Nuclear Factor Erythroid 2-like 2.Molecules2022https://conductscience.org/library/papers/35209068PubMed
1634804354Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris.J Clin Aesthet Dermatol2021https://conductscience.org/library/papers/34804354PubMed
1731709535Skin barrier immunity and ageing.Immunology2020https://conductscience.org/library/papers/31709535PubMed
1838299457
Efficacy of ceramides and niacinamide-containing moisturizer versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris: A split face, double-blinded, randomized controlled trial.
J Cosmet Dermatol2024https://conductscience.org/library/papers/38299457PubMed
1937374920Oral and Topical Probiotics and Postbiotics in Skincare and Dermatological Therapy: A Concise Review.Microorganisms2023https://conductscience.org/library/papers/37374920PubMed
2023914212Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: A double-blinded randomized clinical trial.J Res Med Sci2013https://conductscience.org/library/papers/23914212PubMed

See all 30 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42794388Development of Pharmabiotic Gel-Serums with Lacticaseibacillus casei Postbiotics and Paraprobiotics Using Chitosan and Carbopol.Gels2026https://conductscience.org/library/papers/42794388PubMed
41302077Integration of Postbiotics into Adult Diapers: In Vitro Evaluation of Biocompatibility and Effect on Skin Microbiota.Life (Basel)2025https://conductscience.org/library/papers/41302077PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39768384

GET https://conductscience.org/api/papers/v1/39768384/references?page=2